Skip to main content
. 2016 Jun 2;115(1):108–114. doi: 10.1038/bjc.2016.157

Table 2. Associations between prediagnostic fasting serum biomarkers and meningioma by quartile and gender.

Fasting hazard ratiosa (95% confidence intervals)
Glucose
Glucose levels in quartiles <4.6 mmol l−1 4.6-<5.0 mmol l−1 5.0-<5.5 mmol l−1 ≥5.5 mmol l−1 Ptrendb
Women 1.00 (Ref) 1.10 (0.77-1.57) 0.74 (0.49-1.12) 0.44c (0.26-0.74) 0.0006
Cases, n 60 64 37 20  
Men 1.00 (Ref) 1.62 (0.86-3.06) 1.47 (0.78-2.79) 1.54 (0.82-2.89) 0.24
Cases, n 14 30 31 40  
Cholesterol
Cholesterol levels in quartiles <5.1mmol l−1 5.1-<5.8mmol l−1 5.8-<6.5mmol l−1 ≥6.5mmol l−1 Ptrendb
Women 1.00 (Ref) 1.11 (0.72-1.70) 1.19 (0.76-1.86) 0.85 (0.53-1.37) 0.59
Cases, n 40 48 49 44  
Men 1.00 (Ref) 1.15 (0.70-1.90) 0.63 (0.35-1.13) 0.70 (0.40-1.21) 0.06
Cases, n 29 37 21 28  
Total 1.00 (Ref) 1.13 (0.81-1.56) 0.93 (0.66-1.33) 0.76 (0.53-1.09) 0.08
Cases, n 69 85 70 72  
a

Hazard ratios adjusted for age and date of laboratory test, triglycerides and other biomarkers in table.

b

Polynomial linear trend test.

c

A hazard ratio of 0.44 indicates that women with serum glucose levels of at least 5.5 mmol l−1 have meningioma hazard rates 56% lower than do women with serum glucose levels <4.6 mmol l−1.